Are We Training Too Many Scientists?
Symphony Capital and others hone a biotech-funding model that may offer all parties an upside with less risk.
It?s time to come to grips with how we?re misleading and hurting young aspiring researchers.
The scientific manuscript as we know it has outlived its usefulness. Here's how to move forward.
Scientists must learn lessons from Dr. Death to prevent a war over tissue engineering.
Should we repatriate wild-caught animals? And are some animals more equal than others?
Why should junior investigators get all the glory? Postdocs do most of the work.
Choosing the right chemical warheads for your proteomic problems.
Ajit Varki came to the United States to hear 1970's superbands. He stayed to do super glycobiology research.
Filling in evolutionary blanks is just the first feat for the rat and chicken genomes.
What Supreme Court decisions say about threats to the progress of personalized medicine.
What Wyeth learned about working with the US and European regulatory agencies to mine their pharmacogenomic data.
No company is too small or too successful for a mentoring program to enhance productivity, leadership development, and employee retention.
Making marriage work at the job can be challenging for couples as well as colleagues.